Abstract
Purpose: Many new genetic tests for susceptibility to adult-onset diseases are developed on the basis of selected and high-risk groups. Before such tests can be used in medical practice, however, epidemiologic studies must be conducted to evaluate their clinical sensitivity, specificity, and positive predictive value in the general population. For many common adult-onset diseases, this process may take decades of follow-up.
Method: We illustrate how clinical validation of new predictive genetic tests can be done retrospectively using case-control studies that are derived from population-based registries of diseases. We use the examples of birth defects and cancer registries to illustrate a hypothetical process by which such tests can be clinically validated.
Results: We demonstrate how such epidemiologic studies can be successfully used to derive measures of a test's sensitivity, specificity, positive predictive value, negative predictive value, and of the population attributable fraction of disease due to the disease-susceptibility genes. Under certain assumptions, data derived from population-based case-control studies provide adequate estimates of lifetime risks for disease (penetrance) among people with specified genotypes.
Conclusions: With adequate protections of human subjects, studies involving population-based registries of disease will increasingly become valuable in validating the numerous genetic tests that will emerge from advances in human genetic research and the Human Genome Project.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yang, Q., Khoury, M., Coughlin, S. et al. On the use of population-based registries in the clinical validation of genetic tests for disease susceptibility. Genet Med 2, 186–192 (2000). https://doi.org/10.1097/00125817-200005000-00005
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1097/00125817-200005000-00005
Keywords
This article is cited by
-
Beyond odds ratios — communicating disease risk based on genetic profiles
Nature Reviews Genetics (2009)